Home > Chemicals and Materials > Specialty Chemicals > Custom Synthesis > avidin market
Get a free sample of Avidin Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of Avidin Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Some of the major market players operating in the avidin market are
These players focus on strategic partnerships and new product launches & commercialization for market expansion. Furthermore, they heavily invest in research to introduce innovative products and garner maximum revenue in the market.
The market size off avidin was valued at USD 220 million in 2022 and will reach USD 350 million by 2032, attributed to advancements in various biotechnological applications as well as the rising need for precise & efficient research tools.
The streptavidin segment accounted for a market value of around USD 150 million in 2022, owing to its strong binding affinity for biotin, which forms the basis of the biotin-streptavidin system.
Vector Laboratories, Thermo Fisher Scientific, Merck KGaA (Sigma-Aldrich), Aviva Systems Biology, BioVectra, Cell Signaling Technology, and Avidity.
U.S. dominated North America avidin market with a revenue of USD 62.7 million in 2022 and will expand at a significant pace from 2023